Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 91 AL 105

[Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis]

Sugimoto H.

Yakugaku Zasshi. 2010 Apr;130(4):521-6. doi: 10.1248/yakushi.130.521.

Vitamin E forms in Alzheimer's disease: a review of controversial and clinical experiences

Usoro OB, Mousa SA.

Crit Rev Food Sci Nutr. 2010 May;50(5):414-9. doi: 10.1080/10408390802304222.

Assessing care of vulnerable elders--Alzheimer's disease: a pilot study of a practice redesign intervention to improve the quality of dementia care

Reuben DB, Roth CP, Frank JC, Hirsch SH, Katz D, McCreath H, Younger J, Murawski M, Edgerly E, Maher J, Maslow K, Wenger NS.

J Am Geriatr Soc. 2010 Feb;58(2):324-9. doi: 10.1111/j.1532-5415.2009.02678.x. Epub 2010 Jan 26.

Differential features of burden between spouse and adult-child caregivers of patients with Alzheimer's disease: an exploratory comparative design

Conde-Sala JL, Garre-Olmo J, Turró-Garriga O, Vilalta-Franch J, López-Pousa S.

Int J Nurs Stud. 2010 Oct;47(10):1262-73. doi: 10.1016/j.ijnurstu.2010.03.001. Epub 2010 Apr 5.

Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease

Siemers ER, Friedrich S, Dean RA, Gonzales CR, Farlow MR, Paul SM, Demattos RB.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):67-73. doi: 10.1097/WNF.0b013e3181cb577a.

Consideration of the ischaemic basis and treatment of Alzheimer's disease

Pluta R, Ułamek M, Jabłoński M.

Folia Neuropathol. 2010;48(1):11-26.

Simple choline esters as potential anti-Alzheimer agents

Alcaro S, Arcone R, Costa G, De Vita D, Iannone M, Ortuso F, Procopio A, Pasceri R, Rotiroti D, Scipione L.

Curr Pharm Des. 2010;16(6):692-7. doi: 10.2174/138161210790883796.

Immunotherapy for Alzheimer's disease

Solomon B, Frenkel D.

Neuropharmacology. 2010 Sep-Oct;59(4-5):303-9. doi: 10.1016/j.neuropharm.2010.04.004. Epub 2010 Apr 11.

Aneuploidy and adult neurogenesis in Alzheimer's disease: therapeutic strategies

Taupin P.

Drug Discov Today. 2010 Dec;15(23-24):983-4. doi: 10.1016/j.drudis.2010.04.001. Epub 2010 Apr 13.

Omega-3 fatty acids: potential role in the management of early Alzheimer's disease

Jicha GA, Markesbery WR.

Clin Interv Aging. 2010 Apr 7;5:45-61. doi: 10.2147/cia.s5231.

Anticholinesterase duration in the Australian veteran population

Gadzhanova S, Roughead L, Mackson J.

Aust N Z J Psychiatry. 2010 May;44(5):469-74. doi: 10.3109/00048670903555104.

ACAT inhibition and amyloid beta reduction

Bhattacharyya R, Kovacs DM.

Biochim Biophys Acta. 2010 Aug;1801(8):960-5. doi: 10.1016/j.bbalip.2010.04.003. Epub 2010 Apr 14.

Alzheimer's disease drug discovery: Abeta and beyond

Shineman DW, Fillit HM.

Curr Alzheimer Res. 2010 May;7(3):188-9. doi: 10.2174/156720510791050939.

REVIEW: Curcumin and Alzheimer's disease

Hamaguchi T, Ono K, Yamada M.

CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x.

Current therapeutic targets for the treatment of Alzheimer's disease

Grill JD, Cummings JL.

Expert Rev Neurother. 2010 May;10(5):711-28. doi: 10.1586/ern.10.29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias